Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MGX

Metagenomi Therapeutics Inc

May 11 • 02:31PM ET

1.38

-0.03 -2.13 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: CRBU PRME EDIT BEAM NTLA

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.36	Insider Own	31.03%	Shs Outstand	37.62M	Perf Week	-2.13%
Market Cap	51.91M	Forward P/E	-	EPS next Y	-1.90	Insider Trans	-0.15%	Shs Float	25.95M	Perf Month	0.00%
Enterprise Value	-68.23M	PEG	-	EPS next Q	-0.55	Inst Own	18.19%	Short Float	7.21%	Perf Quarter	-9.80%
Income	-87.87M	P/S	2.06	EPS this Y	10.34%	Inst Trans	4.77%	Short Ratio	8.94	Perf Half Y	-37.84%
Sales	25.21M	P/B	0.33	EPS next Y	9.98%	ROA	-31.50%	Short Interest	1.87M	Perf YTD	-14.81%
Book/sh	4.22	P/C	0.32	EPS next 5Y	6.93%	ROE	-44.67%	52W High	3.95 -65.06%	Perf Year	-8.61%
Cash/sh	4.27	P/FCF	-	EPS past 3/5Y	-26.57% -42.49%	ROIC	-45.47%	52W Low	1.25 10.40%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	13.59% 219.15%	Gross Margin	78.91%	Volatility	4.62% 4.77%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-2.71	EPS Y/Y TTM	9.77%	Oper. Margin	-380.85%	ATR (14)	0.07	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.22	Sales Y/Y TTM	-51.79%	Profit Margin	-348.54%	RSI (14)	43.98	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	7.22	EPS Q/Q	4.24%	SMA20	-3.93%	Beta	0.67	Target Price	9.50
Payout	-	Debt/Eq	0.26	Sales Q/Q	-59.32%	SMA50	-4.48%	Rel Volume	0.88	Prev Close	1.41
Employees	119	LT Debt/Eq	0.22	Earnings	Mar 05 AMC	SMA200	-24.95%	Avg Volume	209.14K	Price	1.38
IPO	Feb 09, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	2.62% -46.64%	Trades		Volume	143,672	Change	-2.13%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)